Literature DB >> 21945167

Dosimetric evaluation of a three-phase adaptive radiotherapy for nasopharyngeal carcinoma using helical tomotherapy.

Winky Wing Ki Fung1, Vincent Wing Cheung Wu, Peter Man Lung Teo.   

Abstract

Adaptive radiotherapy (ART) has been introduced to correct the radiation-induced anatomic changes in head and neck cases during a treatment course. This study evaluated the potential dosimetric benefits of applying a 3-phase adaptive radiotherapy protocol in nasopharyngeal carcinoma (NPC) patients compared with the nonadaptive single-phase treatment protocol. Ten NPC patients previously treated with this 3-phase radiation protocol using Hi-Art Tomotherapy were recruited. Two new plans, PII-ART and PIII-ART, were generated based on the up-to-date computed tomography (CT) images and contours and were used for treatment in phase two (PII; after 25th fraction) and phase three (PIII; after 35th fraction), respectively. To simulate the situation of no replanning, 2 hybrid plans denoted as PII-NART and PIII-NART were generated using the original contours pasted on the PII- and PIII-CT sets by CT-CT fusion. Dosimetric comparisons were made between the NART plans and the corresponding ART plans. In both PII- and PIII-NART plans, the doses to 95% of all the target volumes (D₉₅) were increased with better dose uniformity, whereas the organs at risk (OARs) received higher doses compared with the corresponding ART plans. Without replanning, the total dose to 1% of brainstem and spinal cord (D₁) significantly increased 7.87 ± 7.26% and 10.69 ± 6.72%, respectively (P = 0.011 and 0.001, respectively), in which 3 patients would have these structures overdosed when compared with those with two replannings. The total maximum doses to the optic chiasm and pituitary gland and the mean doses to the left and right parotid glands were increased by 10.50 ± 10.51%, 8.59 ± 6.10%, 3.03 ± 4.48%, and 2.24 ± 3.11%, respectively (P = 0.014, 0.003, 0.053, and 0.046, respectively). The 3-phase radiotherapy protocol showed improved dosimetric results to the critical structures while keeping satisfactory target dose coverage, which demonstrated the advantages of ART in helical tomotherapy of NPC. Copyright Â
© 2012 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21945167     DOI: 10.1016/j.meddos.2011.01.006

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  12 in total

1.  Is it necessary to repeat CT imaging and replanning during the course of intensity-modulated radiation therapy for locoregionally advanced nasopharyngeal carcinoma?

Authors:  Chuanben Chen; Xiang Lin; Jianji Pan; Zhaodong Fei; Lisha Chen; Penggang Bai
Journal:  Jpn J Radiol       Date:  2013-06-09       Impact factor: 2.374

2.  CT-based dose recalculations in head and neck cancer radiotherapy: comparison of daily dose recalculations to less time-consuming approaches.

Authors:  Simon Wagenblast; Severin Kampfer; Kai J Borm; Stephanie E Combs; Steffi U Pigorsch; Marciana-Nona Duma
Journal:  Strahlenther Onkol       Date:  2018-12-06       Impact factor: 3.621

3.  Determining appropriate timing of adaptive radiation therapy for nasopharyngeal carcinoma during intensity-modulated radiation therapy.

Authors:  Huixian Huang; Heming Lu; Guosheng Feng; Hailan Jiang; Jiaxin Chen; Jinjian Cheng; Qiang Pang; Zhiping Lu; Junzhao Gu; Luxing Peng; Shan Deng; Ying Mo; Danling Wu; Yinglin Wei
Journal:  Radiat Oncol       Date:  2015-09-17       Impact factor: 3.481

4.  Target delineation and dose prescription of adaptive replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Authors:  Dehuan Xie; Wanqin Cheng; Shaowen Lv; Rui Zhong; Lei Wang; Jiang Hu; Mingli Wang; Shaomin Huang; Yong Su; Yunfei Xia
Journal:  Cancer Commun (Lond)       Date:  2019-04-15

Review 5.  Adaptive radiotherapy for head and neck cancer.

Authors:  Howard E Morgan; David J Sher
Journal:  Cancers Head Neck       Date:  2020-01-09

6.  Patient- and therapy-related factors associated with the incidence of xerostomia in nasopharyngeal carcinoma patients receiving parotid-sparing helical tomotherapy.

Authors:  Tsair-Fwu Lee; Ming-Hsiang Liou; Hui-Min Ting; Liyun Chang; Hsiao-Yi Lee; Stephen Wan Leung; Chih-Jen Huang; Pei-Ju Chao
Journal:  Sci Rep       Date:  2015-08-20       Impact factor: 4.379

7.  Developing an adaptive radiation therapy strategy for nasopharyngeal carcinoma.

Authors:  Winky Wing Ki Fung; Vincent Wing Cheung Wu; Peter Man Lung Teo
Journal:  J Radiat Res       Date:  2013-08-29       Impact factor: 2.724

8.  A modified VMAT adaptive radiotherapy for nasopharyngeal cancer patients based on CT-CT image fusion.

Authors:  Xiance Jin; Ce Han; Yongqiang Zhou; Jinling Yi; Huawei Yan; Congying Xie
Journal:  Radiat Oncol       Date:  2013-11-27       Impact factor: 3.481

9.  Three-Phase Adaptive Radiation Therapy for Patients With Nasopharyngeal Carcinoma Undergoing Intensity-Modulated Radiation Therapy: Dosimetric Analysis.

Authors:  Shan Deng; Xu Liu; Heming Lu; Huixian Huang; Liuyang Shu; Hailan Jiang; Jinjian Cheng; Luxing Peng; Qiang Pang; Junzhao Gu; Jian Qin; Zhiping Lu; Ying Mo; Danling Wu; Yinglin Wei
Journal:  Technol Cancer Res Treat       Date:  2017-05-17

10.  Adaptive radiotherapy for head and neck cancer reduces the requirement for rescans during treatment due to spinal cord dose.

Authors:  Louise Belshaw; Christina E Agnew; Denise M Irvine; Keith P Rooney; Conor K McGarry
Journal:  Radiat Oncol       Date:  2019-11-01       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.